Skip to content
Home » Explore » Kyoto City FY2020 Start of recruitment for hometown tax-type crowdfunding ~Supporting research and development of regenerative medical technology such as iPS cells~

Kyoto City FY2020 Start of recruitment for hometown tax-type crowdfunding ~Supporting research and development of regenerative medical technology such as iPS cells~

  • ALL

Kyoto City press release (2024.10.01) Kyoto City [FY2020] Start of recruitment for hometown tax-type crowdfunding ~Supporting research and development of regenerative medical technology such as iPS cells~ Would you like to support research and development such as regenerative medical technology with your hometown tax?
https://prcdn.freetls.fastly.net/release_image/59523/300/59523-300-7145989a852751586f8ddc2c5ac78800-500×340.png


                (C) Kyoto University iPS Cell Research Foundation  In Kyoto City, we support the promotion of the practical application of iPS cells by the Kyoto University iPS Cell Research Foundation
(hereinafter referred to as the iPS Foundation), as well as research and development in the life science field undertaken by small and medium-sized enterprises and university researchers in the city. , from FY2020 “Hometown tax-based crowdfunding” is being carried out.  Last year, we received 233 donations totaling approximately 27 million yen, exceeding our goal of 22 million yen, and used them to develop new treatments using regenerative medicine technologies such as iPS cells.   For this year, we will start accepting
applications from October 1st (Tuesday). Please lend your support to this initiative, which will be a light to people around the world suffering from incurable diseases and injuries. 1 Business overview   In order to support research and development in the life science field including regenerative medicine, we will collect the amount of your donation after deducting administrative expenses. 1. Donation to the iPS Foundation 2. Used to support research and development including regenerative medicine by companies and university researchers (subsidy costs for the Kyoto-originated innovative medical technology research and development subsidy project) I will do it.   In addition, if donations exceed the target amount or if the target amount is not reached, the donations will be used for the above purpose. 2.About hometown tax-based crowdfunding ⑴Overview   It is a crowdfunding method that utilizes hometown tax donations, and local governments act as project implementers and collect donations from people who sympathize with the project. A portion of the donor’s income tax and resident tax will be reduced (deducted) according to the donation amount. By indicating the specific use of the raised funds, we will solicit donations from a wide range of people who sympathize with the project, with the aim of genuinely solving social issues, rather than as return gifts.
https://prcdn.freetls.fastly.net/release_image/59523/300/59523-300-c47ebe4797275363a52cbb500e7ba101-288×288.png ⑵ Recruitment method   On the web page “Furusato Choice” operated by Trust Bank Co., Ltd.   We are soliciting donations.    ▼Reception page:
https://www.furusato-tax.jp/gcf/3188 ⑶ Recruitment period    October 1st (Tuesday) – December 31st (Tuesday), 2020 ⑷ Target amount    22 million yen [Reference 1] About the innovative medical technology research and development subsidy project from Kyoto 1 Purpose
   Aiming at university researchers and small and medium-sized businesses in Kyoto City, we will provide information on regenerative medicine and other fields that are expected to grow in the future.    In the field of science, we support research and development that leads to the creation of new medical devices and drugs.    We aim to promote the city’s life science industry by providing an opportunity for business development.  2 Target business     Commercialization of life science fields such as medical devices (including application development), medical materials, pharmaceuticals/diagnostics, and regenerative medicine. Research and development for     3 Implementation status in FY2020 ⑴ Recruitment period   April 1st (Monday) to April 24th (Wednesday), 2020 ⑵ Subsidy period   Subsidy grant decision date to the end of February 2020 (single year) ⑶ Number of accepted projects   13 items (
https://www.city.kyoto.lg.jp/sankan/cmsfiles/contents/0000329/329306/press2.pdf )
https://prcdn.freetls.fastly.net/release_image/59523/300/59523-300-ec5ce7b9c328439199982795ebbe1518-265×300.jpg 4 Examples of support using donations (1) Arktus Therapeutics Co., Ltd. (Sakyo Ward, Kyoto City) ( https://arktustx.com/ ) We are working on the world’s first treatment method for knee cartilage regenerative medicine by combining iPS cells and tissue three-dimensional technology. We are developing products that can treat injuries in areas and large areas that are difficult to treat with conventional methods.
https://prcdn.freetls.fastly.net/release_image/59523/300/59523-300-df2bff863cf63acd06e90265dd95b2bf-300×300.png (2) HiLung Co., Ltd. (Sakyo Ward, Kyoto City) (
https://www.hilung.com/ ) In order to save many people suffering from respiratory diseases such as pneumonia and lung cancer, we manufacture human lung cells in large quantities, conduct research on lung diseases, and predict the effects of therapeutic drug candidates using sophisticated and highly versatile micron-sized technology. Applied and commercialized as a “simulator”. The “iPS lung cells” provided by our company are being used around the world, including in research and drug discovery for the new coronavirus and other viral infections that could cause future pandemics.
https://prcdn.freetls.fastly.net/release_image/59523/300/59523-300-6ce257228b999abf0902ed06a43b6a20-300×197.jpg (3) Regenephro Co., Ltd. (Sakyo Ward, Kyoto City) (
https://www.regenephro.co.jp/ )  A biotechnology company that aims to develop kidney regenerative medicine and drug discovery using iPS cells. In addition to aiming to develop the world’s first cell therapy for chronic kidney disease, we are also conducting clinical trials for a treatment for the incurable kidney disease ADPKD, which we discovered using an iPS cell-derived disease model. In addition, we have numerous pipelines in the liver and pancreas fields as well as the kidneys, and we expect that iPS cells will be put to practical use in a variety of ways. [Reference 2] About donations through the corporate hometown tax payment system In addition to “Hometown Tax Crowdfunding”, Kyoto City also accepts donations through “Corporate Hometown Tax”. Donations are used in the same way as the individual version. For details on the corporate hometown tax donation system and how to donate, please visit the website below. (Kyoto City Information Center) https://www.city.kyoto.lg.jp/sankan/page/0000331607.html [Reference 3] Regarding related events by the iPS Foundation (online lectures for the general public) The iPS Foundation is planning to hold the following online lectures on the current status of its activities and practical application using iPS cell technology. 1 Basics of iPS cells (October 22nd (Tuesday) 12:10-12:50)
   Speaker: iPS Foundation Director of Social Cooperation Office Takayo Hosokawa 2 The research director speaks! “my iPS project” (Wednesday, November 6th, 12:10-12:50)    Speaker: iPS Foundation Executive Director, Research and Development Center Director Masayoshi Tsukahara How to watch: Can be viewed from the “Kyoto University iPS Cell Research Foundation” channel below (no
registration required)   
https://www.youtube.com/channel/UCjULoS139NIxvKMUYmGl8Qg

0 0 votes
Article Rating
guest
0 Comments
Newest
Oldest Most Voted
Inline Feedbacks
View all comments
This article was partly generated by AI. Some links may contain Ads. Press Release-Informed Article.
0
Would love your thoughts, please comment.x
()
x